COVID-19 BILAN KASALLANGAN BEMORLARDA XAVOTIRLI HOLATLARNING RIVOJLANISHIGA TA’SIR KOʻRSATUVCHI OMILLARNI OʻRGANISH
DOI:
https://doi.org/10.47390/3030-3133V1I2Y2023N05Kalit so'zlar:
xavotirli buzilishlar, COVID-19, ruhiy salomatlik, somatopsixikaAnnotatsiya
Soʻnggi oʻn yilliklarda xavotrili buzilish muammosiga ilmiy qiziqish sezilarli darajada oshdi. Xavotirli buzilish pandemiya kabi stressli vaziyatlarga javoban paydo boʻlishi mumkin boʻlgan eng keng tarqalgan ruhiy kasalliklardan biridir. Xavotirli buzilish immunitetning pasayishi, uyqu muammolari, vahima hujumlari va depressiya kabi jiddiy oqibatlarga olib kelishi mumkin. Ushbu maqolada xavotirli buzilishlarning rivojlanishiga ta'sir qiluvchi omillarni aniqlash maqsadida shahar klinik psixiatriya shifoxonasida oʻtkazilgan tadqiqot ma'lumotlari keltirilgan.
Foydalanilgan adabiyotlar
Karavaeva T.A., Korolkova T.N. Psychological mechanisms and psychosomatic relationships in various dermatoses // Klinicheskaya dermatologiya i venerologiya. 2018. Vol. 17, № 5. P. 7.
Lamers F. et al. Comorbidity Patterns of Anxiety and Depressive Disorders in a Large Cohort Study // J Clin Psychiatry. 2011. Vol. 72, № 03. P. 341–348.
DeMartini J., Patel G., Fancher T.L. Generalized anxiety disorder // Ann Intern Med. 2019. Vol. 170, № 7. P. ITC49–ITC64.
Bandelow B., Michaelis S., Wedekind D. Treatment of anxiety disorders // Dialogues Clin Neurosci. 2017. Vol. 19, № 2. P. 93–107.
Vogelzangs N. et al. Anxiety disorders and inflammation in a large adult cohort // Transl Psychiatry. 2013. Vol. 3, № 4. P. e249–e249.
Pająk A. et al. Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study // Eur J Prev Cardiol. 2013. Vol. 20, № 2. P. 331–340.
Craske M.G. et al. What is an anxiety disorder? // Depress Anxiety. 2009. Vol. 26, № 12. P. 1066–1085.
Penninx B.W. et al. Anxiety disorders // The Lancet. 2021. Vol. 397, № 10277. P. 914–927.
Stein D.J. et al. Epidemiology of anxiety disorders: from surveys to nosology and back // Dialogues Clin Neurosci. 2017. Vol. 19, № 2. P. 127–136.
Stanikova D. et al. Associations Between Anxiety, Body Mass Index, and Sex Hormones in Women // Front Psychiatry. 2019. Vol. 10.
Kessler R.C. et al. Epidemiology of anxiety disorders. // Curr Top Behav Neurosci. 2010. Vol. 2. P. 21–35.
Довженко Т.В., Семиглазова М.В., Краснов В.Н. Расстройства тревожно депрессивного спектраи синдром кардиальной боли при сердечно-сосудистых заболеваниях(клинико-психопатологические аспекты) // Социальная и клиническная психиатрия. 2011. Vol. №4. P. 5–13.
Golovacheva V.A., Parfenov V.A. Anxiety disorders under the guiese of vegetovascular dystonia // Medical Council. Remedium, Ltd., 2017. № 17. P. 26–30.
Левин О.С., Ляшенко Е.А. Тревога и коморбидные состояния // Нервные болезни. 2016. Vol. 1. P. 28–34.
Bandelow B., Michaelis S. Epidemiology of anxiety disorders in the 21st century // Dialogues Clin Neurosci. 2015. Vol. 17, № 3. P. 327–335.
Merkin A.G. et al. Anxiety: Phenomenology, epidemiology, and risk factors during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic // Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Ima-Press Publishing House, 2021. Vol. 13, № 1. P. 107–112.
Volel B.A. et al. Cognitive impairment in anxiety disorders // Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Ima-Press Publishing House, 2018. Vol. 10, № 1. P. 78–82.
Lijster J.M. de et al. The Age of Onset of Anxiety Disorders // The Canadian Journal of Psychiatry. 2017. Vol. 62, № 4. P. 237–246.
Phillips A.C. et al. Cytomegalovirus is associated with depression and anxiety in older adults // Brain Behav Immun. 2008. Vol. 22, № 1. P. 52–55.
Baxter A.J. et al. Global prevalence of anxiety disorders: a systematic review and meta-regression // Psychol Med. 2013. Vol. 43, № 5. P. 897–910.
Muntingh A.D. et al. Collaborative care for anxiety disorders in primary care: a systematic review and meta-analysis // BMC Fam Pract. 2016. Vol. 17, № 1. P. 62.
Mendelevich E.G. Somatization of anxiety disorders in the practice of a neurologist: Algorithms and approaches to differentiated treatment // Neurology, Neuropsychiatry, Psychosomatics. IMA Press, LLC, 2014. № 4. P. 81.
Shalnova S.A. et al. The prevalence of anxiety and depression in different regions of the Russian Federation and its association with sociodemographic factors (according to the data of the ESSE-RF study) // Ter Arkh. Media Sphera, 2014. Vol. 86, № 12. P. 53–60.
Santomauro D.F. et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic // The Lancet. 2021. Vol. 398, № 10312. P. 1700–1712.
Soriano J.B. et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus // Lancet Infect Dis. 2022. Vol. 22, № 4. P. e102–e107.
Alkodaymi M.S. et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis // Clinical Microbiology and Infection. 2022. Vol. 28, № 5. P. 657–666.
Huang C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study // The Lancet. 2021. Vol. 397, № 10270. P. 220–232.
Groff D. et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection // JAMA Netw Open. 2021. Vol. 4, № 10. P. e2128568.
Delpino F.M. et al. Prevalence of anxiety during the COVID-19 pandemic: A systematic review and meta-analysis of over 2 million people // J Affect Disord. 2022. Vol. 318. P. 272–282.
